background image

Paid Clinical Trials Fayetteville

Discover 168 paid clinical trials in Fayetteville, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

for
Squamous Cell Carcinoma of Head and Neck
Location: Fayetteville AR, Springdale AR, Rogers AR,
Sponsor: University of Arkansas

Sex: All

Age: 18 - 70+

Code: NCT05952934

Phase2, Recruiting
Active & Responsive

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

for
AAA, AAA - Abdominal Aortic Aneurysm
Location: Fayetteville AR, Little Rock AR, Columbia MO,
Sponsor: Endologix

Sex: All

Age: 21+

Code: NCT05064540

Recruiting
Active & Responsive

A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension

for
Knee Osteoarthritis
Location: Fayetteville AR, South Bend IN, Atlanta GA,
Sponsor: Canary Medical

Sex: All

Age: 18+

Code: NCT06040827

Recruiting
Active & Responsive

Protein and Polycystic Ovary Syndrome (PCOS)

for
Polycystic Ovary Syndrome (PCOS)
Location: Fayetteville AR
Sponsor: University of Arkansas, Fayetteville

Sex: Female

Age: 18 - 50

Code: NCT07158723

Recruiting
Active & Responsive

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Springdale AR, Tulsa OK, Wichita KS, Memphis TN,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer

for
Breast Cancer, Metastatic Breast Cancer
Location: Springdale AR, Merriam KS, Dallas TX, St Louis MO,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05563220

Phase1, Phase2, Recruiting
Active & Responsive

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

for
Hematologic Malignancies, Waldenstroms Macroglobulinaemia,
Location: Springdale AR, Dallas TX, Louisville KY, Rochester MN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04728893

Phase2, Recruiting
Active & Responsive

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Springdale AR, Madison WI, Pembroke Pines FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05947851

Phase3, Recruiting
Active & Responsive

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Springdale AR, Nashville TN, Houston TX, San Antonio TX,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase1, Recruiting
Active & Responsive

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Springdale AR, Merriam KS, Wichita KS, Denison TX,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase2, Phase3, Recruiting